Urology--Certified
Dr. Kibel specializes in the surgical treatment of urologic cancers. He treats all forms of urologic cancers including prostate cancer, kidney cancer, bladder cancer and testis cancer. Whenever possible, he uses minimally invasive approaches, such as laparoscopy, to improve patient comfort and recovery time. These procedures include laparoscopic radical prostatectomy, laparoscopic radical and partial nephrectomy, and laparoscopic cystectomy
Cornell University Medical College, New York, New York, 1991
Residency: General Surgery, Brigham and Women's Hospital, Boston, MA, 1993
Residency: Urology, Harvard Program in Urology, Longwood Area, Boston, MA, 1997
Fellowship: Urologic Oncology, Brady Urological Insitutue, Johns Hopkins Medical Institutions, Baltimore, MD, 1999
Center for Advanced Medicine
Urologic Surgery Center
4921 Parkview Place, Suite C, Floor 11
St. Louis, MO 63110
(314) 362-8295
Fax: (314) 454-5244
Progress West HealthCare Center
Suite G
2 Progress Point Parkway
O'Fallon, Missouri 63368
(314) 362-8295
Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
St Louis Children's Hospital
St Louis VA Medical Center
Progress West HealthCare Center
National/International Awards and Honors:
Young Investigator Award, Society of Urologic Oncology, 2006: Awarded to the urologic surgeon who has contributed the most to cancer care in the first 10 years of practice.
American Urological Association/European Association of Urology Traveling Fellow, 2004: Awarded to 3 prominent urologic surgeons in the North America every other year.
American College of Surgeons Faculty Research Fellow 2000-2002: Awarded for research in prostate cancer aggressiveness.
American Association for Cancer Research Young Investigator Award, 1999: Awarded for research into the causes of prostate cancer.
American Foundation for Urologic Disease Research Scholar, 1997-1999: Awarded for research into causes of prostate cancer.
Pfizer Scholar in Urology, 1996: Awarded for outstanding achievement.
Noonan-Wheeler FC, Wu W, Roehl KA, Klim A, Haugen J, Suarez BK, Kibel AS. Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma. Prostate. 2005 Aug 20; [Epub ahead of print]
Kibel AS. An interdisciplinary approach to treating prostate cancer. Urology. 2005;65(6 Suppl):13-18.
Belani JS, Farooki A, Prasad S, Yan Y, Heiken JP, Kibel AS. Parenchymal imaging adds diagnostic utility in evaluating haematuria. BJU International. 2005;95(1):64-67.
Grubb RL 3rd, Collyer WC, Kibel AS. Transitional cell carcinoma of the renal pelvis associated with hypercalcemia in a patient with autosomal dominant polycystic kidney disease. Urology. 2004;63(4):778-780.
Kibel AS, Huagen J, Guo C, Isaacs WB, Yan Y, Pienta KJ, Goodfellow PJ. Expression mapping at 12p12-13 in advanced prostate carcinoma. International Journal of Cancer. 2004;109(5):668-672.
Bhayani SB, Clayman RV, Sundaram CP, Landman J, Andriole G, Figenshau RS, Bullock A, Brandes S, Shalhav A, McDougall E, Kibel AS. Surgical treatment of renal neoplasia: evolving toward a laparoscopic standard of care. Urology. 2003;62(5):821-826.
Kibel AS, Faith DA, Bova GS, Isaacs WB. Xq27-28 deletions in prostate carcinoma. Genes Chromosomes Cancer. 2003;37(4):381-388.
Kibel AS, Suarez BK, Belani J, Oh J, Webster R, Brophy-Ebbers M, Guo C, Catalona WJ, Picus J, Goodfellow PJ. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma. Cancer Research. 2003;63(9):2033-2036.
Oyama N, Miller TR, Dehdashti F, Siegel BA, Fischer KC, Michalski JM, Kibel AS, Andriole GL, Picus J, Welch MJ. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. Journal of Nuclear Medicine. 2003;44(4):549-555.
Yan Y, Andriole GL, Humphrey PA, Kibel AS. Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors. Cancer. 2002;95(6):1239-1246.
Kibel AS, Faith DA, Bova GS, Isaacs WB. Mutational analysis of ETV6 in prostate carcinoma. Prostate. 2002;52(4):305-310.
Kibel AS, Christopher M, Faith DA, Bova GS, Goodfellow PJ, Isaacs WB. Methylation and mutational analysis of p27(kip1) in prostate carcinoma. Prostate. 2001;48(4):248-253.
Kibel AS, Isaacs WB. G(1)/S cell cycle proteins as markers of aggressive prostate carcinoma. Urology. 2000;55(3):316-322.
Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science. 1995;269:1444-1446.
Iliopoulos O, Kibel A, Gray S, Kaelin WG. Tumor suppression by the human von Hippel-Lindau gene product. Nature Medicine. 1995;1:822-826.
Pub Med page for Adam S. Kibel, M.D.
Kibel AS, Nelson JB. Molecular Genetics and Cancer Biology. In: Walsh PC, Wein AJ, Vaughan ED, Retik AB (eds.). Campbell's Urology. 8th edition. Philadelphia: W.B. Saunders; 2002:2625-2671 (Chapter 74).
Kibel AS, DeWolf WC. Epidemiology of Renal Cell Carcinoma. In: Ernstoff MS, Heaney JA, Peschel RE (eds.). Urologic Cancer. Blackwell Science; 1997:348-356 (Chapter 24).
|
